BIOMAT Database Logo BIOMAT Database Logo

Slow-release verapamil and hyperglycemic metabolic acidosis. 1989

A Roth, and H I Miller, and B Belhassen, and S Laniado

UI MeSH Term Description Entries
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000138 Acidosis A pathologic condition of acid accumulation or depletion of base in the body. The two main types are RESPIRATORY ACIDOSIS and metabolic acidosis, due to metabolic acid build up. Metabolic Acidosis,Acidoses,Acidoses, Metabolic,Acidosis, Metabolic,Metabolic Acidoses
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014700 Verapamil A calcium channel blocker that is a class IV anti-arrhythmia agent. Iproveratril,Calan,Cordilox,Dexverapamil,Falicard,Finoptin,Isoptin,Isoptine,Izoptin,Lekoptin,Verapamil Hydrochloride,Hydrochloride, Verapamil

Related Publications

A Roth, and H I Miller, and B Belhassen, and S Laniado
[Slow-release verapamil poisoning].
March 1997, Anales de medicina interna (Madrid, Spain : 1984),
A Roth, and H I Miller, and B Belhassen, and S Laniado
Pharmacokinetics of conventional and slow-release verapamil.
January 1986, British journal of clinical pharmacology,
A Roth, and H I Miller, and B Belhassen, and S Laniado
Profound hyperglycemia and metabolic acidosis after verapamil overdose.
December 1983, Journal of the American College of Cardiology,
A Roth, and H I Miller, and B Belhassen, and S Laniado
Serum concentration and antihypertensive effect of slow-release verapamil.
January 1982, Journal of cardiovascular pharmacology,
A Roth, and H I Miller, and B Belhassen, and S Laniado
[Bioavailability of two slow-release formulations of verapamil].
October 1990, Arzneimittel-Forschung,
A Roth, and H I Miller, and B Belhassen, and S Laniado
The bioavailability of a slow-release verapamil formulation.
June 1985, British journal of clinical practice. Supplement,
A Roth, and H I Miller, and B Belhassen, and S Laniado
[The toxicity of slow-release verapamil and chronic kidney disease].
November 1994, Revista espanola de cardiologia,
A Roth, and H I Miller, and B Belhassen, and S Laniado
[Abdominal pain and hyperglycemic acidosis].
January 2002, Duodecim; laaketieteellinen aikakauskirja,
A Roth, and H I Miller, and B Belhassen, and S Laniado
The efficacy of a slow-release formulation of verapamil.
June 1985, British journal of clinical practice. Supplement,
A Roth, and H I Miller, and B Belhassen, and S Laniado
Comparative bioavailability of verapamil from rapidly absorbed and slow release preparations.
January 1992, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!